Share-based Payment Arrangement, Expense in USD of Instil Bio, Inc. from Q1 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Instil Bio, Inc. quarterly and annual Share-based Payment Arrangement, Expense history and change rate from Q1 2020 to Q3 2025.
  • Instil Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $1,768,000, a 57% decline year-over-year.
  • Instil Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $11,588,000, a 33% decline year-over-year.
  • Instil Bio, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $17,257,000, a 5% decline from 2023.
  • Instil Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $18,166,000, a 40% decline from 2022.
  • Instil Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $30,441,000, a 16% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Instil Bio, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $11,588,000 $1,768,000 -$2,300,000 -57% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $13,888,000 $1,824,000 -$2,349,000 -56% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $16,237,000 $3,495,000 -$1,020,000 -23% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $17,257,000 $4,501,000 -$52,000 -1.1% 01 Oct 2024 31 Dec 2024 10-K 04 Mar 2025 2024 FY
Q3 2024 $17,309,000 $4,068,000 -$602,000 -13% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $17,911,000 $4,173,000 -$240,000 -5.4% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 $18,151,000 $4,515,000 -$15,000 -0.33% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $18,166,000 $4,553,000 -$2,090,000 -31% 01 Oct 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 $20,256,000 $4,670,000 -$3,312,000 -41% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $23,568,000 $4,413,000 -$3,910,000 -47% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $27,478,000 $4,530,000 -$2,963,000 -40% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q4 2022 $30,441,000 $6,643,000 -$2,263,000 -25% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 $32,704,000 $7,982,000 -$752,000 -8.6% 01 Jul 2022 30 Sep 2022 10-Q/A 13 Nov 2023 2023 Q3
Q2 2022 $33,456,000 $8,323,000 +$2,578,000 +45% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $30,878,000 $7,493,000 +$4,681,000 +166% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $26,197,000 $8,906,000 +$8,492,000 +2051% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $17,705,000 $8,734,000 +$8,403,000 +2539% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $9,302,000 $5,745,000 +$4,846,000 +539% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022 2022 Q2
Q1 2021 $4,456,000 $2,812,000 +$2,750,000 +4435% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q4 2020 $1,706,000 $414,000 01 Oct 2020 31 Dec 2020 10-K 07 Mar 2022 2021 FY
Q3 2020 $331,000 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $899,000 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $62,000 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1

Instil Bio, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $17,257,000 -$909,000 -5% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2025 2024 FY
2023 $18,166,000 -$12,275,000 -40% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
2022 $30,441,000 +$4,244,000 +16% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
2021 $26,197,000 +$24,491,000 +1436% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $1,706,000 01 Jan 2020 31 Dec 2020 10-K 07 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.